A Case of Posterior Reversible Encephalopathy Syndrome Associated With Pembrolizumab and Cetuximab Combination Therapy

By sjmartinez • November 20, 2024

Patel N, Karanth R, Isaacs DJ, Cohen J, Wong DJ, Delshad SD. A Case of Posterior Reversible Encephalopathy Syndrome Associated With Pembrolizumab and Cetuximab Combination Therapy. Cureus. 2024 Oct 19;16(10):e71867. doi: 10.7759/cureus.71867. PMID: 39559603; PMCID: PMC11573227.

Tags: cancer immunotherapy, Cetuximab, General Internal Medicine, hematology-oncology, Hematology/Oncology, Hospitalist, immune-related adverse event, irae, pembrolizumab side effect, posterior reversible encephalopathy syndrome, pres, Publications

Primary Cardiac Angiosarcoma Leading to Tamponade and Fatal Right Atrial Rupture

Makaroff KE, Hampilos K, Sayed S, Emert B, Hu X, Nsair A, Kwon M, Middlekauff H. Primary Cardiac Angiosarcoma Leading to Tamponade and Fatal Right[...]

Long COVID Persistence and Surveillance Gaps Across 58 US Hospitals

Tian J, Azhir A, Decaro M, Chau N, Hügel J, Morris M, Cheng J, Fard P, Bassett IV, Bell DS, Bernstam EV, Visweswaran S, Klann[...]

Use of Evidence-Based Type 2 Diabetes Preventive Therapies and Rates of Progression to Diabetes Among Veterans with Prediabetes by Race and Ethnicity, 2010-2019

Ly DP, Washington DL, Shekelle PG, Lee ML, Moin T. Use of Evidence-Based Type 2 Diabetes Preventive Therapies and Rates of Progression to Diabetes Among[...]